TOURMALINE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.68 USD | -2.00% |
|
+1.49% | -40.11% |
Chart calendar Tourmaline Bio, Inc.
35b3c00b46.ycA4WFdrMym8BIwcC2_QL8gpZimCuMfbFK24AmgC74g.g7RTLmNYZG_uNOd-eF2pH79nDxvx6LKoRu7gNjlP1-z_oXINGyVZWNZVuA~269da8d6307b9bfc2657961064084fcf
Upcoming events on Tourmaline Bio, Inc.
No events available
Past events on Tourmaline Bio, Inc.
| 2024-03-19 07:00 am | Q4 2023 Earnings Release |
| 2024-03-13 10:00 am | Leerink Partners Global Biopharma Conference |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-02-07 11:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-06-13 09:00 am | Annual General Meeting |
| 2022-11-29 04:20 pm | Evercore ISI HealthCONx Conference |
| 2022-11-10 07:00 am | Q3 2022 Earnings Release |
| 2022-11-05 05:51 pm | American Society of Nephrology Meeting - Absract Number: SA-OR50 |
| 2022-11-05 05:33 pm | American Society of Nephrology Meeting - Absract Number: SA-OR48 |
| 2022-10-10 | Cell & Gene Meeting - Pre-recorded |
| 2022-09-28 01:00 pm | William Blair Innovations In Solid Organ And Hematopoietic Stem Cell Transplant Virtual Conference |
| 2022-09-14 09:00 am | H.C. Wainwright Global Investment Conference |
| 2022-09-12 01:40 pm | Morgan Stanley Global Healthcare Conference |
| 2022-08-15 07:00 am | Interim 2022 Earnings Release |
| 2022-06-30 08:00 am | American Transplant Congress |
| 2022-06-09 01:00 pm | Annual General Meeting |
| 2022-06-08 10:30 am | Jefferies Healthcare Conference |
| 2022-06-08 08:00 am | American Transplant Congress |
| 2022-06-07 07:00 pm | American Transplant Congress - Poster No 9090 |
| 2022-06-07 03:30 pm | American Transplant Congress - Oral No 409 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -45,4 -53,1 14.46% | -70,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -42,1 -55,1 23.53% | -71,8 |
|
Net income Million USD | Released Forecast Spread | -19,7 | -42,1 -56,0 24.82% | -66,3 |
|
EPS USD | Released Forecast Spread | -1,79 | -8,87 -4,15 -113.94% | -2,95 |
| Announcement Date | 20/07/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,93 -14,4 37.76% | -14,9 -13,8 -7.86% | -15,8 | -17,0 | -18,2 | -19,7 | -14,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,02 -14,4 51.12% | -12,9 -15,8 18.55% | -15,7 | -17,0 | -18,5 | -20,6 | -14,1 |
|
Net income Million USD | Released Forecast Spread | -7,02 -14,4 51.12% | -12,9 -15,8 18.36% | -15,0 | -15,8 | -17,0 | -18,5 | -14,1 |
|
EPS USD | Released Forecast Spread | -1,64 -0,71 -132.62% | -0,81 -0,77 -5.19% | -0,67 | -0,69 | -0,73 | -0,79 | -0,86 |
| Announcement Date | 14/11/23 | 19/03/24 | - | - | - | - | - |
More events
Past sector events for Tourmaline Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRML Stock
- Calendar Tourmaline Bio, Inc.
